Risk of urogenital infections in non-diabetic patients treated with sodium glucose transporter 2 (SGLT2) inhibitors. Systematic review and meta-analysis. Arch Ital Urol Androl [Internet]. 2023 Jun. 13 [cited 2026 Apr. 29];95(2). Available from: https://www.pagepressjournals.org/aiua/article/view/11509